Immunoglobulin G (IgG) Class, but Not IgA or IgM, Antibodies to Peptides of the Porphyromonas gingivalis Chaperone HtpG Predict Health in Subjects with Periodontitis by a Fluorescence Enzyme-Linked Immunosorbent Assay

ABSTRACT Chaperones are molecules found in all cells and are critical in stabilization of synthesized proteins, in repair/removal of defective proteins, and as immunodominant antigens in innate and adaptive immunity. Subjects with gingivitis colonized by the oral pathogen Porphyromonas gingivalis previously demonstrated levels of anti-human chaperone Hsp90 that were highest in individuals with the best oral health. We hypothesized that similar antibodies to pathogen chaperones might be protective in periodontitis. This study examined the relationship between antibodies to P. gingivalis HtpG and clinical statuses of healthy and periodontitis-susceptible subjects. We measured the humoral responses (immunoglobulin G [IgG], IgA, and IgM) to peptides of a unique insert (P18) found in Bacteroidaceae HtpG by using a high-throughput, quantitative fluorescence enzyme-linked immunosorbent assay. Indeed, higher levels of IgG class anti-P. gingivalis HtpG P18 peptide (P < 0.05) and P18α, consisting of the N-terminal 16 amino acids of P18 (P < 0.05), were associated with better oral health; these results were opposite of those found with anti-P. gingivalis whole-cell antibodies and levels of the bacterium in the subgingival biofilm. When we examined the same sera for IgA and IgM class antibodies, we found no significant relationship to subject clinical status. The relationship between anti-P18 levels and clinical populations and individual subjects was found to be improved when we normalized the anti-P18α values to those for anti-P18γ (the central 16 amino acids of P18). That same ratio correlated with the improvement in tissue attachment gain after treatment (P < 0.05). We suggest that anti-P. gingivalis HtpG P18α antibodies are protective in periodontal disease and may have prognostic value for guidance of individual patient treatment.

[1]  Jill L. Johnson,et al.  Hsp90 and co-chaperones twist the functions of diverse client proteins. , 2010, Biopolymers.

[2]  C. Engeland,et al.  Sex hormones and mucosal wound healing , 2009, Brain, Behavior, and Immunity.

[3]  T. Braun,et al.  Identification of pathogen and host-response markers correlated with periodontal disease. , 2009, Journal of periodontology.

[4]  K. Sonomoto,et al.  Molecular chaperones in lactic acid bacteria: physiological consequences and biochemical properties. , 2008, Journal of bioscience and bioengineering.

[5]  W. Coulter,et al.  Serum Antibodies to Porphyromonas gingivalis Chaperone HtpG Predict Health in Periodontitis Susceptible Patients , 2008, PloS one.

[6]  J. Beck,et al.  Periodontal disease at the biofilm-gingival interface. , 2007, Journal of periodontology.

[7]  J. Cacioppo,et al.  Depressive Symptoms Predict Mucosal Wound Healing , 2007, Psychosomatic medicine.

[8]  S. Calderwood,et al.  Extracellular heat shock proteins in cell signaling , 2007, FEBS letters.

[9]  P. Eke,et al.  Case Definitions for Use in Population-Based Surveillance of Periodontitis. , 2007, Journal of periodontology.

[10]  D. Lopatin,et al.  HtpG, the Porphyromonas gingivalis HSP‐90 homologue, induces the chemokine CXCL8 in human monocytic and microvascular vein endothelial cells , 2007, Cellular microbiology.

[11]  S. Anil,et al.  Serum antibody levels in smoker and non-smoker saudi subjects with chronic periodontitis. , 2007, Journal of periodontology.

[12]  H. Yoshikawa,et al.  Studies on the role of HtpG in the tetrapyrrole biosynthesis pathway of the cyanobacterium Synechococcus elongatus PCC 7942. , 2007, Biochemical and biophysical research communications.

[13]  R. Medzhitov,et al.  TLR4 Up-Regulation at Protein or Gene Level Is Pathogenic for Lupus-Like Autoimmune Disease1 , 2006, The Journal of Immunology.

[14]  J. A. Aas,et al.  The breadth of bacterial diversity in the human periodontal pocket and other oral sites. , 2006, Periodontology 2000.

[15]  S. Socransky,et al.  Microbiological goals of periodontal therapy. , 2006, Periodontology 2000.

[16]  S. Socransky,et al.  Introduction to microbial aspects of periodontal biofilm communities, development and treatment. , 2006, Periodontology 2000.

[17]  I. Ishikawa,et al.  Immunoglobulin G subclass antibody profiles in Porphyromonas gingivalis-associated aggressive and chronic periodontitis patients. , 2006, Oral microbiology and immunology.

[18]  M. Listgarten,et al.  Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis subgingival presence, species-specific serum immunoglobulin G antibody levels, and periodontitis disease recurrence. , 2006, Journal of periodontal research.

[19]  Sung-Jo Kim,et al.  Porphyromonas gingivalis heat shock protein vaccine reduces the alveolar bone loss induced by multiple periodontopathogenic bacteria. , 2006, Journal of periodontal research.

[20]  J. Ravetch,et al.  Divergent Immunoglobulin G Subclass Activity Through Selective Fc Receptor Binding , 2005, Science.

[21]  P. Srivastava,et al.  The heat-shock protein receptors: some answers and more questions. , 2004, Tissue antigens.

[22]  R. Binder,et al.  Essential role of CD91 in re-presentation of gp96-chaperoned peptides. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[23]  A. Jl.  Diagnosis of Periodontal Diseases. , 2004, Journal of periodontology.

[24]  D. Grenier,et al.  Oral microbial heat-shock proteins and their potential contributions to infections. , 2003, Critical reviews in oral biology and medicine : an official publication of the American Association of Oral Biologists.

[25]  A. McGregor,et al.  The systemic immune response is more prominent than the mucosal immune response in the pathogenesis of periodontal disease. , 2003, Journal of clinical periodontology.

[26]  D. Lopatin,et al.  Construction and characterization of a Porphyromonas gingivalis htpG disruption mutant. , 2003, FEMS microbiology letters.

[27]  A. Kage,et al.  Salivary IgA in response to periodontal treatment. , 2003, European journal of oral sciences.

[28]  Lilah M. Besser,et al.  Specific, Sensitive, and Quantitative Enzyme-Linked Immunosorbent Assay for Human Immunoglobulin G Antibodies to Anthrax Toxin Protective Antigen , 2002, Emerging infectious diseases.

[29]  A. Heinecke,et al.  Longitudinal association between plaque and gingival bleeding in smokers and non-smokers. , 2002, Journal of clinical periodontology.

[30]  L. Wolff,et al.  Quantitative reverse transcription polymerase chain reaction analysis of Porphyromonas gingivalis gene expression in vivo. , 2002, Journal of microbiological methods.

[31]  M C Downer,et al.  Meta-analysis of measures of performance reported in oral cancer and precancer screening studies , 2002, British Dental Journal.

[32]  H. Mitchell,et al.  Major Differences in the IgG Subclass Response to Helicobacter pylori in the First and Third Worlds , 2002, Scandinavian journal of gastroenterology.

[33]  R. Page,et al.  Immunoglobulin G response of periodontitis patients to Porphyromonas gingivalis capsular carbohydrate and lipopolysaccharide antigens. , 2001, Oral microbiology and immunology.

[34]  P. Srivastava,et al.  CD91 is a common receptor for heat shock proteins gp96, hsp90, hsp70, and calreticulin. , 2001, Immunity.

[35]  S. Holt,et al.  Periodontal diseases: to protect or not to protect is the question? , 2001, Acta odontologica Scandinavica.

[36]  K. Tabeta,et al.  Elevated humoral immune response to heat shock protein 60 (hsp60) family in periodontitis patients , 2000, Clinical and experimental immunology.

[37]  Sangeeta Dhamija,et al.  Characterization of Heat-Inducible Expression and Cloning of HtpG (Hsp90 Homologue) of Porphyromonas gingivalis , 2000, Infection and Immunity.

[38]  W. Coulter,et al.  Quantitation of Bacteroides forsythus in subgingival plaque comparison of immunoassay and quantitative polymerase chain reaction. , 2000, Journal of microbiological methods.

[39]  C. Edwards,et al.  Cellular localization of a Hsp90 homologue in Porphyromonas gingivalis. , 1999, FEMS microbiology letters.

[40]  C. Kowalski,et al.  Humoral immunity to stress proteins and periodontal disease. , 1999, Journal of periodontology.

[41]  L. Fu,et al.  IgG subclass/IgM ratio and response to therapy in focal segmental glomerulosclerosis , 1998, Pediatric Nephrology.

[42]  B. Henderson,et al.  Commensal Communism and the Oral Cavity , 1998, Journal of dental research.

[43]  R. Stockley,et al.  IgG subclasses in the serum and sputum from patients with bronchiectasis , 1998, Thorax.

[44]  G. Greenstein.  Contemporary interpretation of probing depth assessments: diagnostic and therapeutic implications. A literature review. , 1997, Journal of periodontology.

[45]  J. Gunsolley,et al.  The effect of race, smoking and immunoglobulin allotypes on IgG subclass concentrations. , 1997, Journal of periodontal research.

[46]  G. Seymour,et al.  Antibody responses of Porphyromonas gingivalis infected gingivitis and periodontitis subjects. , 2008, Oral diseases.

[47]  H. Lu,et al.  Serum immunoglobulin G subclass concentrations in periodontally healthy and diseased individuals , 1994, Infection and immunity.

[48]  D. Lopatin,et al.  Avidity and titer of immunoglobulin G subclasses to Porphyromonas gingivalis in adult periodontitis patients. , 1992, Oral microbiology and immunology.

[49]  L. Wolff,et al.  Dark-pigmented Bacteroides species in subgingival plaque of adult patients on a rigorous recall program. , 1988, Journal of periodontal research.

[50]  I. Lamster,et al.  Lysosomal and cytoplasmic enzyme activity, crevicular fluid volume, and clinical parameters characterizing gingival sites with shallow to intermediate probing depths. , 1987, Journal of periodontology.

[51]  R. Page.  Current understanding of the aetiology and progression of periodontal disease. , 1986, International dental journal.

[52]  R. McHugh,et al.  Comparison of surgical and nonsurgical treatment of periodontal disease. A review of current studies and additional results after 61/2 years. , 1983, Journal of clinical periodontology.

[53]  H. Löe,et al.  EXPERIMENTAL GINGIVITIS IN MAN. , 1965, The Journal of periodontology.